Log in or Sign up for Free to view tailored content for your specialty!
Reproduction/Androgen Disorders News
Hypogonadism may greatly increase mortality odds for hospitalized adults with asthma
NEW ORLEANS — Adults with asthma and hypogonadism have greatly increased risk for mortality during hospitalization compared with adults with asthma and normal testosterone levels, according to data presented at the AACE annual meeting.
Testosterone therapy not tied to additional metabolic benefits for older men with obesity
Testosterone therapy did not improve cardiometabolic measures for older men with obesity and hypogonadism receiving lifestyle intervention, according to findings published in The Journal of Clinical Endocrinology & Metabolism.
Log in or Sign up for Free to view tailored content for your specialty!
Menopause transition does not increase risk for depressive symptoms for all women
Women are not universally at risk for depressive symptoms during menopause transition, but providers should be aware of risk factors and treat mental health disorders promptly, according to a review published in The Lancet.
Testosterone therapy does not improve most psychosocial measures for men with hypogonadism
Testosterone replacement therapy did not improve most quality of life and psychosocial measures for men with pathological hypogonadism who were at high risk for type 2 diabetes, according to study findings.
More studies needed to assess effects of inositol on PCOS outcomes
Findings on the use of inositol for managing polycystic ovary syndrome are inconclusive, with results varying based on therapy, trial design and outcomes reported, according to a systematic review and meta-analysis.
Testosterone therapy does not slow progression to diabetes, increase odds for remission
Testosterone replacement therapy alone did not lower risk for progression from prediabetes to diabetes or increase the likelihood of type 2 diabetes remission among men with hypogonadism, according to study data.
FDA: Food packaging in US will no longer contain PFAS endocrine-disrupting chemicals
A class of endocrine-disrupting chemical called per- and polyfluoroalkyl substances (PFAS) is no longer being used in food packaging in the U.S., according to an announcement from the FDA.
VIDEO: New thyroid dysfunction presenting postpartum can be easy to miss
In this video exclusive, Nicole Gomez, MD, talks with Caroline T. Nguyen, MD, about diagnosing and managing thyroid dysfunction in the postpartum period.
Phthalate exposure linked to higher odds for preterm birth, low birth weight
Exposure to phthalates may have contributed to 56,595 preterm births, resulting in an additional $3.84 billion in health care costs in the U.S. during 2018, according to study data.
Phthalate exposure linked to higher odds for preterm birth, low birth weight
Exposure to phthalates may have contributed to 56,595 preterm births, resulting in an additional $3.84 billion in health care costs in the U.S. during 2018, according to study data.
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read